Future of COVID-19 Treatment Without Vaccine and Painful Needles

Main Article Content

Dr. Gohar Azeem
Erick Jones

Abstract

Ever since the beginning of COVID-19
Pandemic, researchers from all across the
the world has been investigating different
options for the treatment of SARS-COV-2.
This is critical even after two years
from the start of the pandemic due to different
variants resulting in new waves of this virus
spreading globally. In this regard, December
22 and 23rd, 2021 are landmark days, when
FDA granted authorization to Pfizer’s
Paxlovid and Merck’s Molnupiravir
(COVID-19 Oral Antiviral products) for
emergency use (EUA)

Article Details

Section
Articles